Atlas Trials

Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study

Clinical trial NCT04669990 · UNKNOWN

Trial details

NCT number
NCT04669990
Sponsor
Nepal Health Research Council
Status
UNKNOWN
Study type
OBSERVATIONAL
Covid19
Start date
2020-11-19
Primary completion
2021-10-31
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.